• Publications
  • Influence
Remission in schizophrenia: proposed criteria and rationale for consensus.
The first consensus-based operational criteria for symptomatic remission in schizophrenia are based on distinct thresholds for reaching and maintaining improvement, as opposed to change criteria, allowing for alignment with traditional concepts of remission in both psychiatric and nonpsychiatric illness.
The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.
A test-retest reliability study of the Structured Clinical Interview for DSM-III-R was conducted on 592 subjects in four patient and two nonpatient sites in this country as well as one patient site
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
Weight gain and changes in lipid and metabolic parameters in patients without prior antipsychotic medication exposure are studied and mean levels increased significantly for total cholesterol, triglycerides, and non-high-density lipoprotein cholesterol.
Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
A large generalized deficit and more subtle differential deficits were observed even in patients with less severe generalized deficit, but the pattern was unlike the amnestic syndrome and probably reflects different mechanisms.
What does the PANSS mean?
Physical health monitoring of patients with schizophrenia.
A consensus panel's recommendations for improving the physical health monitoring of patients with schizophrenia who are treated in outpatient settings, including regular monitoring of body mass index, plasma glucose level, lipid profiles, and signs of prolactin elevation or sexual dysfunction are discussed.
The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). II: Multi-site test-retest reliability study
A test-retest reliability study of the Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II) was conducted on 284 subjects in four psychiatric patient sites and two
Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia
It was found that runs of homozygosity (ROHs), ranging in size from 200 kb to 15 mb, were common in unrelated Caucasians, and several of these risk ROHs were very rare in healthy subjects, suggesting that recessive effects of relatively high penetrance may explain a proportion of the genetic liability for SCZ.
Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic.
Long-acting injectable risperidone was efficacious and well tolerated and provides both clinicians and patients with a new mode of treatment that can improve the outcome of long-term therapy.